Form 4: Former NEOGEN CEO Adent Exercises RSUs

Former NEOGEN CEO John Edward Adent exercised Restricted Stock Units, acquiring 32,936 shares of common stock and disposing of 9,297 shares for tax purposes.

Summary

• John Edward Adent, former CEO of NEOGEN CORP, reported transactions on October 7, 2025, involving the company's common stock.
• Adent acquired 32,936 shares of common stock through the vesting and settlement of Restricted Stock Units (RSUs) at an exercise price of $5.63 per share.
• Concurrently, 9,297 shares of common stock were disposed of at $5.63 per share, likely to cover tax liabilities associated with the RSU vesting.
• Following these reported transactions, Adent directly beneficially owns 330,651 shares of NEOGEN common stock.
• The transactions were executed pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The vesting of RSUs is a positive event for the executive, and the continued significant holding of shares by a former CEO is generally viewed as a neutral to slightly positive signal. The disposition of shares is for tax purposes and not indicative of a negative outlook on the company.

Positives

• Former CEO Adent continues to hold a significant number of shares (330,651), indicating continued alignment with shareholder interests.
• The acquisition of shares stems from the vesting of RSUs, a common form of equity compensation, reflecting the fulfillment of long-term incentive plans.

Negatives

• A portion of the acquired shares (9,297 shares) was disposed of, reducing the overall beneficial ownership slightly, although this is a standard practice for tax withholding upon RSU vesting and not indicative of a negative outlook.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction report is a routine disclosure of equity compensation vesting and tax-related share disposition. It does not provide specific insights into broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The transaction is a routine insider filing and is unlikely to have a significant direct impact on shareholders. The former CEO's continued substantial holding may be viewed positively.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Keywords

NEOGEN, NEOG, Form 4, Insider Transaction, RSU, Stock Vesting, John Edward Adent, Equity Compensation